Antonio Ocampo

3.0k total citations
86 papers, 1.8k citations indexed

About

Antonio Ocampo is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Antonio Ocampo has authored 86 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 33 papers in Epidemiology and 31 papers in Virology. Recurrent topics in Antonio Ocampo's work include HIV/AIDS drug development and treatment (36 papers), HIV Research and Treatment (31 papers) and HIV/AIDS Research and Interventions (26 papers). Antonio Ocampo is often cited by papers focused on HIV/AIDS drug development and treatment (36 papers), HIV Research and Treatment (31 papers) and HIV/AIDS Research and Interventions (26 papers). Antonio Ocampo collaborates with scholars based in Spain, United States and United Kingdom. Antonio Ocampo's co-authors include Hernando Knobel, Celia Miralles, Jordi Alonso, Javier Juega, José María Kindelán, Isabel Ruíz-Camps, Alexia Carmona, José L. Casado, Julio Collazos and Pedro Diz Dios and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Antonio Ocampo

80 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Ocampo Spain 22 1.0k 704 587 336 223 86 1.8k
Guillem Sirera Spain 24 1.1k 1.1× 767 1.1× 778 1.3× 285 0.8× 391 1.8× 59 2.0k
Reto Nüesch Switzerland 23 660 0.6× 480 0.7× 463 0.8× 114 0.3× 259 1.2× 51 1.7k
Mauro Zaccarelli Italy 25 1.2k 1.2× 498 0.7× 953 1.6× 162 0.5× 218 1.0× 91 1.7k
Barry S. Zingman United States 20 985 0.9× 652 0.9× 438 0.7× 123 0.4× 345 1.5× 57 1.6k
Josep M. Gatell Spain 22 991 0.9× 780 1.1× 575 1.0× 360 1.1× 233 1.0× 61 1.6k
Kenneth Tapia United States 23 857 0.8× 495 0.7× 478 0.8× 70 0.2× 141 0.6× 57 1.3k
Mamta K. Jain United States 24 586 0.6× 1.0k 1.4× 229 0.4× 799 2.4× 227 1.0× 113 1.8k
Kathleen C. Wood United States 20 2.2k 2.1× 1.3k 1.9× 1.2k 2.1× 339 1.0× 1.5k 6.7× 29 3.3k
Anders Blaxhult Sweden 26 1.6k 1.5× 959 1.4× 1.0k 1.8× 249 0.7× 498 2.2× 73 2.2k
Joan Romeu Spain 26 1.6k 1.5× 524 0.7× 1.4k 2.4× 61 0.2× 532 2.4× 67 2.3k

Countries citing papers authored by Antonio Ocampo

Since Specialization
Citations

This map shows the geographic impact of Antonio Ocampo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Ocampo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Ocampo more than expected).

Fields of papers citing papers by Antonio Ocampo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Ocampo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Ocampo. The network helps show where Antonio Ocampo may publish in the future.

Co-authorship network of co-authors of Antonio Ocampo

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Ocampo. A scholar is included among the top collaborators of Antonio Ocampo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Ocampo. Antonio Ocampo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pérez‐González, Alexandre, et al.. (2025). Emergence of multidrug-resistant Haemophilus parainfluenzae isolates from urethral samples in men who have sex with men. Sexually Transmitted Infections. sextrans–2025.
2.
3.
Castro, Jorge, et al.. (2025). Benchmarking Open-Source Large Language Models on Code-Switched Tagalog-English Retrieval Augmented Generation. Journal of Advances in Information Technology. 16(2). 233–242.
4.
Palacios, Rosario, Cristina Gómez‐Ayerbe, José L. Casado, et al.. (2023). Efficacy and safety of dolutegravir/rilpivirine in real‐world clinical practice. GeSIDA study 1119. HIV Medicine. 24(8). 933–937. 3 indexed citations
5.
6.
Crespo, Manuel, Jordi Navarro, Santiago Moreno, et al.. (2016). Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group. Enfermedades Infecciosas y Microbiología Clínica. 35(8). 493–498. 1 indexed citations
7.
García, Féderico, Eva Poveda, Maria Jesús Pérez‐Elías, et al.. (2014). Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48‐week analysis of the PROTEST study. Journal of the International AIDS Society. 17(4S3). 19520–19520. 1 indexed citations
8.
Bernardino, José Ignacio, Federico Pulido, Estebán Martínez, et al.. (2013). Switching to lopinavir/ritonavir with or without abacavir/lamivudine in lipoatrophic patients treated with zidovudine/abacavir/lamivudine. Journal of Antimicrobial Chemotherapy. 68(6). 1373–1381. 10 indexed citations
9.
Rallón, Norma, Judit Morelló, Pablo Labarga, et al.. (2011). Impact of Inosine Triphosphatase Gene Variants on the Risk of Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated for Chronic Hepatitis C. Clinical Infectious Diseases. 53(12). 1291–1295. 10 indexed citations
10.
Fernández-García, Aurora, Lucía Pérez-Álvarez, María Teresa Cuevas, et al.. (2010). Identification of a New HIV Type 1 Circulating BF Intersubtype Recombinant Form (CRF47_BF) in Spain. AIDS Research and Human Retroviruses. 26(7). 827–832. 28 indexed citations
11.
Ocampo, Antonio, et al.. (2009). Prevalence of HLA-B*5701 in HIV-Infected Patients in Spain (Results of the EPI Study). HIV Clinical Trials. 10(1). 48–51. 1 indexed citations
12.
Pérez-Álvarez, Lucía, Valentina E. Garcia, Antonio Ocampo, et al.. (2008). HIV Type 1 Intersubtype Recombinants during the Evolution of a Dual Infection with Subtypes B and G. AIDS Research and Human Retroviruses. 24(2). 337–343. 7 indexed citations
13.
Fernández-García, Aurora, María Teresa Cuevas, Antonio Ocampo, et al.. (2008). Development of a Panel of Well-Characterized Human Immunodeficiency Virus Type 1 Isolates from Newly Diagnosed Patients Including Acute and Recent Infections. AIDS Research and Human Retroviruses. 25(1). 93–102. 17 indexed citations
14.
Pérez-Álvarez, Lucía, Elena Delgado, Celia Miralles, et al.. (2006). Isolation and biological characterization of HIV-1 BG intersubtype recombinants and other genetic forms circulating in Galicia, Spain. Journal of Medical Virology. 78(12). 1520–1528. 14 indexed citations
15.
Jain, Mamta K., Lorraine Comanor, A. Clinton White, et al.. (2006). Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV‐coinfected patients: factors associated with response. Journal of Viral Hepatitis. 14(3). 176–182. 53 indexed citations
16.
Dios, Pedro Diz, et al.. (2005). Detection of HCV-RNA in Saliva of HIV-HCV Coinfected Patients. AIDS Research and Human Retroviruses. 21(12). 1011–1014. 9 indexed citations
17.
Pérez-Álvarez, Lucía, Rocío Carmona, Antonio Ocampo, et al.. (2005). Long-term monitoring of genotypic and phenotypic resistance to T20 in treated patients infected with HIV-1. Journal of Medical Virology. 78(2). 141–147. 40 indexed citations
18.
Ocampo, Antonio, et al.. (2004). Remission of HIV-associated myelopathy after highly active antiretroviral therapy.. PubMed. 50(3). 195–6. 5 indexed citations
19.
Casado, Gema, Michael M. Thomson, Elena Delgado, et al.. (2003). Near Full-Length Genome Characterization of an HIV Type 1 CRF05_DF Virus from Spain. AIDS Research and Human Retroviruses. 19(8). 719–725. 7 indexed citations
20.
Knobel, Hernando, Jordi Alonso, José L. Casado, et al.. (2002). Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. AIDS. 16(4). 605–613. 355 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guillem Sirera Breakdown of academic impact, for papers by Reto Nüesch Breakdown of academic impact, for papers by Mauro Zaccarelli Breakdown of academic impact, for papers by Barry S. Zingman Breakdown of academic impact, for papers by Josep M. Gatell Breakdown of academic impact, for papers by Kenneth Tapia Breakdown of academic impact, for papers by Mamta K. Jain Breakdown of academic impact, for papers by Kathleen C. Wood Breakdown of academic impact, for papers by Anders Blaxhult Breakdown of academic impact, for papers by Joan Romeu
Rankless by CCL
2026